Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GD2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 126 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tur, MK; Sasse, S; Stocker, M; Djabelkhir, K; Huhn, M; Matthey, B; Gottstein, C; Pfitzner, T; Engert, A; Barth, S
      An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    2. Mehes, G; Luegmayr, A; Ambros, IM; Ladenstein, R; Ambros, PF
      Combined automatic immunological and molecular cytogenetic analysis allowsexact identification and quantification of tumor cells in the bone marrow

      CLINICAL CANCER RESEARCH
    3. Reuland, P; Geiger, L; Thelen, MH; Handgretinger, R; Haase, B; Muller-Schauenburg, W; Niethammer, D; Bares, R
      Follow-up in neuroblastoma: Comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    4. Luo, HM; Ding, SY; Hsu, YY; Lin, BN; Ku, HC
      Weak ferromagnetism in distorted T '-phase cuprates

      PHYSICA C
    5. Mielcarek, S; Mroz, B; Tylczynski, Z; Piskunowicz, P; Trybula, Z; Bromberek, M
      Low-temperature thermal conductivity of ferroelastic Gd-2(MoO4)(3)

      PHYSICA B
    6. Kushner, BH; Kramer, K; Cheung, NKV
      Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma

      JOURNAL OF CLINICAL ONCOLOGY
    7. Stern, CA; Tiemeyer, M
      A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons

      JOURNAL OF NEUROSCIENCE
    8. Wachsman, M; Kulka, M; Smith, CC; Aurelian, L
      A growth and latency compromised herpes simplex virus type 2 mutant (ICP10Delta PK) has prophylactic and therapeutic protective activity in guinea pigs

      VACCINE
    9. Wroblewski, JM; Bixby, DL; Borowski, C; Yannelli, JR
      Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens

      LUNG CANCER
    10. Mehes, G; Luegmayr, A; Hattinger, CM; Lorch, T; Ambros, IM; Gadner, H; Ambros, PF
      Automatic detection and genetic profiling of disseminated neuroblastoma cells

      MEDICAL AND PEDIATRIC ONCOLOGY
    11. Rossig, C; Bollard, CM; Nuchtern, JG; Merchant, DA; Brenner, MK
      Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes

      INTERNATIONAL JOURNAL OF CANCER
    12. Engler, S; Thiel, C; Forster, K; David, K; Bredehorst, R; Juhl, H
      A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: Growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies

      CANCER RESEARCH
    13. Yoshida, S; Fukumoto, S; Kawaguchi, H; Sato, S; Ueda, R; Furukawa, K
      Ganglioside G(D2) in small cell lung cancer cell lines: Enhancement of cell proliferation and mediation of apoptosis

      CANCER RESEARCH
    14. Shurin, GV; Shurin, MR; Bykovskaia, S; Shogan, J; Lotze, MT; Barksdale, EM
      Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function

      CANCER RESEARCH
    15. Kaucic, K; Etue, N; LaFleur, B; Woods, W; Ladisch, S
      Neuroblastomas of infancy exhibit a characteristic ganglioside pattern

      CANCER
    16. Hoon, DSB; Kuo, CT; Wen, SH; Wang, H; Metelitsa, L; Reynolds, CP; Seeger, RC
      Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow

      AMERICAN JOURNAL OF PATHOLOGY
    17. Sorkin, LS
      Antibody activation and immune reactions: Potential linkage to pain and neuropathy

      PAIN MEDICINE
    18. Parkhomovskiy, N; Kammesheidt, A; Martin, PT
      N-acetyllactosamine and the CT carbohydrate antigen mediate agrin-dependent activation of MuSK and acetylcholine receptor clustering in skeletal muscle

      MOLECULAR AND CELLULAR NEUROSCIENCE
    19. Vazquez, AM; Gabri, MR; Hernandez, AM; Alonso, DF; Beausoleil, I; Gomez, DE; Perez, R
      Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides

      ONCOLOGY REPORTS
    20. Zeytin, HE; Tripathi, PK; Bhattacharya-Chatterjee, M; Foon, KA; Chatterjee, SK
      Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2

      CANCER GENE THERAPY
    21. Ku, HC; Luo, HM; Lin, BN; Chi, YP; Hsu, YY; Sun, YP; Lee, TJ
      Effect of crystal symmetry on O '-phase weak ferromagnetism

      PHYSICA B
    22. Lake, DF; Huynh, WC; Hersh, EM
      Natural and induced human antibody response to cancer

      CANCER INVESTIGATION
    23. Kanazawa, J; Ohta, S; Shitara, K; Fujita, F; Fujita, M; Hanai, N; Akinaga, S; Okabe, M
      Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    24. Bhattachary-Chatterjee, M; Baral, RN; Chatterjee, SK; Das, R; Zeytin, H; Chakraborty, M; Foon, KA
      Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versusmultiple-epitope antigen vaccine

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    25. Chen, RL; Reynolds, CP; Seeger, RC
      Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    26. Brezicka, T; Bergman, B; Olling, S; Fredman, P
      Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues

      LUNG CANCER
    27. Bhattacharya-Chatterjee, M; Chatterjee, SK; Foon, KA
      Anti-idiotype vaccine against cancer

      IMMUNOLOGY LETTERS
    28. Lode, HN; Xiang, R; Perri, P; Pertl, U; Lode, A; Gillies, SD; Reisfeld, RA
      What to do with targeted IL-2

      DRUGS OF TODAY
    29. Lunn, MPT; Johnson, LA; Fromholt, SE; Itonori, S; Huang, J; Vyas, AA; Hildreth, JEK; Griffin, JW; Schnaar, RL; Sheikh, KA
      High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: Reexamination of GD1a immunolocalization

      JOURNAL OF NEUROCHEMISTRY
    30. Aybar, MJ; Genta, SB; Riera, ANS; Sanchez, SS
      Participation of the GM1 ganglioside in the gastrulation of anuran amphibian Bufo arenarum

      JOURNAL OF EXPERIMENTAL ZOOLOGY
    31. Kendra, K; Malkovska, V; Allen, M; Guzman, J; Albertini, M
      In vivo binding and antitumor activity of ch14.18

      JOURNAL OF IMMUNOTHERAPY
    32. Bergman, I; Pohl, CR; Venkataramanan, R; Burckart, GJ; Stabin, M; Barmada, MA; Griffin, JA; Cheung, NKV
      Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats

      JOURNAL OF IMMUNOTHERAPY
    33. Batova, A; Kamps, A; Gillies, SD; Reisfeld, RA; Yu, AL
      The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro

      CLINICAL CANCER RESEARCH
    34. Bunn, PA
      Immune therapy for lung cancer - Are we getting closer?

      AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    35. Fonti, R; Cheung, NKV; Bridger, GJ; Guo, HF; Abrams, MJ; Larson, SM
      Tc-99m-Monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors

      NUCLEAR MEDICINE AND BIOLOGY
    36. Montaldo, PG; Pagnan, G; Raffaghello, L; Pastorino, F; Allen, TM; Kirchmeier, M; Ponzoni, M
      Anti GD2-immunoliposome-mediated targeting of [I-125] metaiodobenzylguanidine to neuroblastoma and melanoma cells in vitro

      JOURNAL OF LIPOSOME RESEARCH
    37. Yates, AJ; Franklin, TK; McKinney, P; Collins, R; Comas, T; Boesel, CP; Pearl, DK
      Gangliosides and neutral glycolipids in ependymal, neuronal and primitive neuroectodermal tumors

      JOURNAL OF MOLECULAR NEUROSCIENCE
    38. Qiu, JP; Luo, P; Wasmund, K; Steplewski, Z; Kieber-Emmons, T
      Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines

      HYBRIDOMA
    39. Kim, SK; Ragupathi, G; Musselli, C; Choi, SJ; Park, YS; Livingston, PO
      Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugatecancer vaccines

      VACCINE
    40. Estevez, F; Carr, A; Solorzano, L; Valiente, O; Mesa, C; Barroso, O; Sierra, GV; Fernandez, LE
      Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP)

      VACCINE
    41. Hyuga, S; Yamagata, S; Takatsu, Y; Hyuga, M; Nakanishi, H; Furukawa, K; Yamagata, T
      Suppression by ganglioside GD1a of migration capability, adhesion to vitronectin and metastatic potential of highly metastatic FBJ-LL cells

      INTERNATIONAL JOURNAL OF CANCER
    42. SEN G; CHAKRABORTY M; FOON KA; REISFELD RA; BHATTACHARYACHATTERJEE M
      INDUCTION OF IGG ANTIBODIES BY AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2

      Journal of immunotherapy
    43. FUKUDA M; HORIBE K; FURUKAWA K
      ENHANCEMENT OF IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF ANTI-GD2 MONOCLONAL-ANTIBODY-220-51 AGAINST HUMAN NEUROBLASTOMA BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    44. KUO CT; BOSTICK PJ; IRIE RF; MORTON DL; CONRAD AJ; HOON DSB
      ASSESSMENT OF MESSENGER-RNA OF BETA-1-]4-N-ACETYLGALACTOSAMINYLTRANSFERASE AS A MOLECULAR MARKER FOR METASTATIC MELANOMAL

      Clinical cancer research
    45. KUO CT; BOSTICK PJ; IRIE RF; MORTON DL; CONRAD AJ; HOON DSB
      ASSESSMENT OF MESSENGER-RNA OF BETA-1-]4-N-ACETYLGALACTOSAMINYLTRANSFERASE AS A MOLECULAR MARKER FOR METASTATIC MELANOMAL

      Clinical cancer research
    46. CHEUNG NKV; KUSHNER BH; CHEUNG IY; KRAMER K; CANETE A; GERALD W; BONILLA MA; FINN R; YEH SJ; LARSON SM
      ANTI-GD(2) ANTIBODY TREATMENT OF MINIMAL RESIDUAL STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE

      Journal of clinical oncology
    47. YU AL; UTTENREUTHERFISCHER MM; HUANG CS; TSUI CC; GILLIES SD; REISFELD RA; KUNG FH
      PHASE-I TRIAL OF A HUMAN-MOUSE CHIMERIC ANTI-DISIALOGANGLIOSIDE MONOCLONAL-ANTIBODY CH14.18 IN PATIENTS WITH REFRACTORY NEUROBLASTOMA AND OSTEOSARCOMA

      Journal of clinical oncology
    48. SCHULTES BC; BAUM RP; NIESEN A; NOUJAIM AA; MADIYALAKAN R
      ANTIIDIOTYPE INDUCTION THERAPY - ANTI-CA125 ANTIBODIES (AB(3)) MEDIATED TUMOR KILLING IN PATIENTS TREATED WITH OVAREX MAB B43.13 (AB(1))

      Cancer immunology and immunotherapy
    49. SINGH M; CARLSON JR; BRIONES M; UGOZZOLI M; KAZZAZ J; BARACKMAN J; OTT G; OHAGAN D
      A COMPARISON OF BIODEGRADABLE MICROPARTICLES AND MF59 AS SYSTEMIC ADJUVANTS FOR RECOMBINANT GD FROM HSV-2

      Vaccine
    50. LODE HN; XIANG R; BECKER JC; GILLIES SD; REISFELD RA
      IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY

      Pharmacology & therapeutics (Oxford)
    51. OLSHEFSKI R; LADISCH S
      SYNTHESIS, SHEDDING, AND INTERCELLULAR TRANSFER OF HUMAN MEDULLOBLASTOMA GANGLIOSIDES - ABROGATION BY A NEW INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE

      Journal of neurochemistry
    52. BRAMS P; NGUYEN ML; CHAMAT S; ROYSTON I; MORROW PR
      ANTIGEN-SPECIFIC IGG RESPONSES FROM NAIVE HUMAN SPLENOCYTES - IN-VITRO PRIMING FOLLOWED BY ANTIGEN BOOST IN THE SCID MOUSE

      The Journal of immunology
    53. SIETSMA H; NIJHOF W; DONTJE B; VELLENGA E; KAMPS WA; KOK JW
      INHIBITION OF HEMATOPOIESIS IN-VITRO BY NEUROBLASTOMA-DERIVED GANGLIOSIDES

      Cancer research
    54. ZHANG ZQ; IRIE RF; CHI DDJ; HOON DSB
      CELLULAR IMMUNO-PCR - DEFECTION OF A CARBOHYDRATE TUMOR-MARKER

      The American journal of pathology
    55. ALBERTINI MR; HANK JA; SCHILLER JH; KHORSAND M; BORCHERT AA; GAN J; BECHHOFER R; STORER B; REISFELD RA; SONDEL PM
      PHASE IB TRIAL OF CHIMERIC ANTIDISIALOGANGLIOSIDE ANTIBODY PLUS INTERLEUKIN-2 FOR MELANOMA PATIENTS

      Clinical cancer research
    56. FUKUMOTO S; YAMAMOTO A; HASEGAWA T; ABE K; TAKAMIYA K; OKADA M; MIN ZJ; FURUKAWA K; MIYAZAKI H; TSUJI Y; GOTO G; SUZUKI M; SHIKU H; FURUKAWA K
      GENETIC REMODELING OF GANGLIOSIDES RESULTED IN THE ENHANCED REACTIONSTO THE FOREIGN SUBSTANCES IN SKIN

      Glycobiology
    57. HEINEMANN S; SHARP TG; SEIFERT F; RUBIE DC
      THE CUBIC-TETRAGONAL PHASE-TRANSITION IN THE SYSTEM MAJORITE (MG4SI4O12) PYROPE (MG3AL2SI3O12), AND GARNET SYMMETRY IN THE EARTHS TRANSITION ZONE

      Physics and chemistry of minerals
    58. SLART R; YU AL; YAKSH TL; SORKIN LS
      AN ANIMAL-MODEL OF PAIN PRODUCED BY SYSTEMIC ADMINISTRATION OF AN IMMUNOTHERAPEUTIC ANTIGANGLIOSIDE ANTIBODY

      Pain
    59. XIAO WH; YU AL; SORKIN LS
      ELECTROPHYSIOLOGICAL CHARACTERISTICS OF PRIMARY AFFERENT-FIBERS AFTERSYSTEMIC ADMINISTRATION OF ANTI-GD2 GANGLIOSIDE ANTIBODY

      Pain
    60. LADISCH S; CHANG FM; LI RX; COGEN P; JOHNSON D
      DETECTION OF MEDULLOBLASTOMA AND ASTROCYTOMA-ASSOCIATED GANGLIOSIDE C-D3 IN CEREBROSPINAL-FLUID

      Cancer letters
    61. MOUTEL S; BIRKLE S; LAURENCE V; MICHON J; FRIDMAN WH; AUBRY J; TEILLAUD JL
      GENERATION AND CHARACTERIZATION OF A MOUSE SINGLE-CHAIN ANTIBODY FRAGMENT SPECIFIC FOR DISIALOGANGLIOSIDE (G(D2))

      Hybridoma
    62. HEISS P; BERMATZ S; WEHNES H; HEINZMANN U; SENEKOWITSCHSCHMIDTKE R
      DISTRIBUTION OF DISIALOGANGLIOSIDE G(D2)-ANTIGEN AND BINDING OF ANTI-G(D2) ANTIBODIES ON SPHEROIDS OF NEUROBLASTOMA CELL-LINE

      Anticancer research
    63. JUHL H; PETRELLA EC; CHEUNG NKV; BREDEHORST R; VOGEL CW
      ADDITIVE CYTOTOXICITY OF DIFFERENT MONOCLONAL-ANTIBODY COBRA VENOM FACTOR CONJUGATES FOR HUMAN NEUROBLASTOMA-CELLS

      Immunobiology
    64. RAVEENDRAN P; SUKUMAR N; SRINIVASAN TKK
      TEMPERATURE-DEPENDENCE OF PHONON-ASSISTED EXCITATION PROBABILITY IN GDTB(MOO4)(3) - EVIDENCE FOR A CHANGE IN ELECTRON-LATTICE COUPLING NEARA STRUCTURAL PHASE-TRANSITION

      Physical review. B, Condensed matter
    65. YUKI N; YAMADA M; TAGAAWA Y; TAKAHASHI H
      PATHOGENESIS OF THE NEUROTOXICITY CAUSED BY ANTI-GD2 ANTIBODY THERAPY

      Journal of the neurological sciences
    66. RIGGOTT MJ; MATTHEW WD
      NEURITE OUTGROWTH IS ENHANCED BY ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES TO THE GANGLIOSIDE GM1

      Experimental neurology
    67. CHANG FM; LI RX; LADISCH S
      SHEDDING OF GANGLIOSIDES BY HUMAN MEDULLOBLASTOMA CELLS

      Experimental cell research
    68. FROST JD; HANK JA; REAMAN GH; FRIERDICH S; SEEGER RC; GAN J; ANDERSON PM; ETTINGER LJ; CAIRO MS; BLAZAR BR; KRAILO MD; MATTHAY KK; REISFELD RA; SONDEL PM
      A PHASE I IB TRIAL OF MURINE MONOCLONAL ANTI-GD2 ANTIBODY 14.G2A PLUSINTERLEUKIN-2 IN CHILDREN WITH REFRACTORY NEUROBLASTOMA - A REPORT OFTHE CHILDRENS CANCER GROUP/

      Cancer
    69. VRIESENDORP FJ; QUADRI SM; FLYNN RE; MALONE MR; CROMEENS DM; STEPHENS LC; VRIESENDORP HM
      PRECLINICAL ANALYSIS OF RADIOLABELED ANTI-GD2 IMMUNOGLOBULIN-G

      Cancer
    70. DAVID K; OLLERT MW; JUHL H; VOLLMERT C; ERTTMANN R; VOGEL CW; BREDEHORST R
      GROWTH ARREST OF SOLID HUMAN NEUROBLASTOMA XENOGRAFTS IN NUDE RATS BYNATURAL IGM FROM HEALTHY HUMANS

      Nature medicine
    71. ALBERTINI MR; GAN J; JAEGER P; HANK JA; STORER B; SCHELL K; RIVEST T; SURFUS J; REISFELD RA; SCHILLER JH; SONDEL PM
      SYSTEMIC INTERLEUKIN-2 MODULATES THE ANTIIDIOTYPIC RESPONSE TO CHIMERIC ANTI-GD2 ANTIBODY IN PATIENTS WITH MELANOMA

      Journal of immunotherapy with emphasis on tumor immunology
    72. MURRAY JL; KLEINERMAN ES; JIA SF; ROSENBLUM MG; ETON O; BUZAID A; LEGHA S; ROSS MI; THOMPSON L; MUJOO K; RIEGER PT; SALEH M; KHAZAELI MB; VADHANRAJ S
      PHASE-IA IB TRIAL OF ANTI-GD2 CHIMERIC MONOCLONAL-ANTIBODY-14.18 (CH14.18) AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN METASTATIC MELANOMA/

      Journal of immunotherapy with emphasis on tumor immunology
    73. UGUR O; KOSTAKOGLU L; HUI ET; FISHER DR; GARMESTANI K; GANSOW OA; CHEUNG NKV; LARSON SM
      COMPARISON OF THE TARGETING CHARACTERISTICS OF VARIOUS RADIOIMMUNOCONJUGATES FOR RADIOIMMUNOTHERAPY OF NEUROBLASTOMA - DOSIMETRY CALCULATIONS INCORPORATING CROSS-ORGAN BETA DOSES

      Nuclear medicine and biology
    74. RIGGOTT MJ; MATTHEW WD
      ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES TO GM1 IDENTIFY GANGLIOSIDE BINDING-PROTEINS

      Glycobiology
    75. GRANT SC; KOSTAKOGLU L; KRIS MG; YEH SDJ; LARSON SM; FINN RD; OETTGEN HF; CHEUNG NKV
      TARGETING OF SMALL-CELL LUNG-CANCER USING THE ANTI-GD2 GANGLIOSIDE MONOCLONAL-ANTIBODY 3F8 - A PILOT TRIAL

      European journal of nuclear medicine
    76. SCHWARZ A; FUTERMAN AH
      THE LOCALIZATION OF GANGLIOSIDES IN NEURONS OF THE CENTRAL-NERVOUS-SYSTEM - THE USE OF ANTIGANGLIOSIDE ANTIBODIES

      Biochimica et biophysica acta, MR. Reviews on biomembranes
    77. LI RX; GAGE D; MCKALLIP R; LADISCH S
      STRUCTURAL CHARACTERIZATION AND IN-VIVO IMMUNOSUPPRESSIVE ACTIVITY OFNEUROBLASTOMA G(D2)

      Glycoconjugate journal
    78. BISHOP JAN
      CURRENT IMMUNOTHERAPY FOR MELANOMA

      Cancer surveys
    79. RAVINDRANATH MH; BAUER PM; CORNILLEZTY C; GARCIA J; MORTON DL
      QUANTITATION OF THE DENSITY OF CELL-SURFACE CARBOHYDRATE ANTIGENS ON CANCER-CELLS WITH A SENSITIVE CELL-SUSPENSION ELISA

      Journal of immunological methods
    80. FURUKAWA K; SOEJIMA H; NIIKAWA N; SHIKU H; FURUKAWA K
      GENOMIC ORGANIZATION AND CHROMOSOMAL ASSIGNMENT OF THE HUMAN BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE GENE - IDENTIFICATION OF MULTIPLE TRANSCRIPTION UNITS

      The Journal of biological chemistry
    81. TARDIF M; COULOMBE J; SOULIERES D; ROUSSEAU AP; PELLETIER G
      GANGLIOSIDES IN HUMAN UVEAL MELANOMA METASTATIC PROCESS

      International journal of cancer
    82. LU P; SHAROM FJ
      IMMUNOSUPPRESSION BY YAC-1 LYMPHOMA - ROLE OF SHED GANGLIOSIDES

      Cellular immunology
    83. HELFAND SC; HANK JA; GAN J; SONDEL PM
      LYSIS OF HUMAN TUMOR-CELL LINES BY CANINE COMPLEMENT PLUS MONOCLONAL ANTIGANGLIOSIDE ANTIBODIES OR NATURAL CANINE XENOANTIBODIES

      Cellular immunology
    84. MARQUINA G; WAKI H; FERNANDEZ LE; KON K; CARR A; VALIENTE O; PEREZ R; ANDO S
      GANGLIOSIDES EXPRESSED IN HUMAN BREAST-CANCER

      Cancer research
    85. HANDGRETINGER R
      COMBINATION IMMUNOTHERAPY WITH MONOCLONAL-ANTIBODIES AND CYTOKINES FOR NEUROBLASTOMA

      International journal of pediatric hematology/oncology
    86. MICHON J; PERDEREAU B; BRIXY F; MOUTEL S; FRIDMAN WH; TEILLAUD JL
      IN-VIVO TARGETING OF HUMAN NEUROBLASTOMA XENOGRAFT BY ANTI-G(D2)ANTI-FC-GAMMA-RI (CD64) BISPECIFIC ANTIBODY

      European journal of cancer
    87. HANDGRETINGER R; ANDERSON K; LANG P; DOPFER R; KLINGEBIEL T; SCHRAPPE M; REULAND P; GILLIES SD; REISFELD RA; NIETHAMMER D
      A PHASE-I STUDY OF HUMAN MOUSE CHIMERIC ANTIGANGLIOSIDE GD2 ANTIBODY CH14.18 IN PATIENTS WITH NEUROBLASTOMA

      European journal of cancer
    88. SATOH J; KIM SU
      GANGLIOSIDE MARKERS GD3, GD2, AND A2B5 IN FETAL HUMAN NEURONS AND GLIAL-CELLS IN CULTURE

      Developmental neuroscience
    89. UTTENREUTHERFISCHER MM; HUANG CS; YU AL
      PHARMACOKINETICS OF HUMAN-MOUSE CHIMERIC ANTI-GD2 MAB CH14.18 IN A PHASE-I TRIAL IN NEUROBLASTOMA PATIENTS

      Cancer immunology and immunotherapy
    90. HOLZER U; BETHGE W; KRULL F; IHLE J; HANDGRETINGER R; REISFELD RA; DOHLSTEN M; KALLAND T; NIETHAMMER D; DANNECKER GE
      UPERANTIGEN-STAPHYLOCOCCAL-ENTEROTOXIN-A-DEPENDENT AND ANTIBODY-TARGETED LYSIS OF GD(2)-POSITIVE NEUROBLASTOMA-CELLS

      Cancer immunology and immunotherapy
    91. UTTENREUTHERFISCHER MM; HUANG CS; REISFELD RA; YU AL
      PHARMACOKINETICS OF ANTIGANGLIOSIDE GD2 MAB 14G2A IN A PHASE-I TRIAL IN PEDIATRIC CANCER-PATIENTS

      Cancer immunology and immunotherapy
    92. BARBUTO JAM; GRIMES WJ; HERSH EM
      ANTIBODIES TO TUMOR-NECROSIS-FACTOR - A COMPONENT OF B-CELL IMMUNE-RESPONSES WITH A ROLE IN TUMOR HOST INTERACTION

      Cancer immunology and immunotherapy
    93. ARBIT E; CHEUNG NKV; YEH SDJ; DAGHIGHIAN F; ZHANG JJ; CORDONCARDO C; PENTLOW K; CANETE A; FINN R; LARSON SM
      QUANTITATIVE STUDIES OF MONOCLONAL-ANTIBODY TARGETING TO DISIALOGANGLIOSIDE G(D2) IN HUMAN BRAIN-TUMORS

      European journal of nuclear medicine
    94. BOLETI E; GEORGE AJT; EPENETOS AA
      THERAPEUTIC MONOCLONALS

      Biochemical Society transactions
    95. MADIYALAKAN R; SYKES TR; DHARAMPAUL S; SYKES CJ; BAUM RP; HOR G; NOUJAIM AA
      ANTIIDIOTYPE INDUCTION THERAPY - EVIDENCE FOR THE INDUCTION OF IMMUNE-RESPONSE THROUGH THE IDIOTYPE NETWORK IN PATIENTS WITH OVARIAN-CANCERAFTER ADMINISTRATION OF ANTI-CA125 MURINE MONOCLONAL-ANTIBODY B43.13

      Hybridoma
    96. KIKUMOTO Y; OKA T; CAO JN; SZE L; IRIE RF
      PEPTIDES WITH CARBOXYL-TERMINAL SEQUENCE OF ALANINE PROLINE - DETECTION BY A HUMAN MONOCLONAL-ANTIBODY

      Hybridoma
    97. ZHAO XJ; CHEUNG NKV
      G(D2) OLIGOSACCHARIDE - TARGET FOR CYTOTOXIC T-LYMPHOCYTES

      The Journal of experimental medicine
    98. LU P; SHAROM FJ
      GANGLIOSIDES ARE POTENT IMMUNOSUPPRESSORS OF IL-2-MEDIATED T-CELL PROLIFERATION IN A LOW-PROTEIN ENVIRONMENT

      Immunology
    99. MICHON J; MOUTEL S; BARBET J; ROMETLEMONNE JL; DEO YM; FRIDMAN WH; TEILLAUD JL
      IN-VITRO KILLING OF NEUROBLASTOMA-CELLS BY NEUTROPHILS DERIVED FROM GRANULOCYTE-COLONY-STIMULATING FACTOR-TREATED CANCER-PATIENTS USING AN ANTI-DISIALOGANGLIOSIDE ANTI-FC-GAMMA-RI BISPECIFIC ANTIBODY

      Blood
    100. DYATLOVITSKAYA EV
      SPHINGOLIPIDS AND MALIGNANT GROWTH

      Biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/01/21 alle ore 20:31:56